ABSTRACT
An integrative analysis of miRNA and mRNA expression profiles in left ventricle (LV) of diabetes-induced rats was performed to elucidate the role of miRNAs and their mRNAs target in diabetic cardiomyopathy (DCM). mRNA (GSE4745) and miRNA (GSE44179) datasets were downloaded from Gene Expression Omnibus 2R (GEO2R) and differentially expressed mRNAs and miRNAs were selected. Cardiotoxicity-related mRNAs (n=7) were analyzed by Ingenuity Pathway Analyses 6 (IPA) and regulatory miRNAs (n=639) were identified using TargetScan 7.1. web dataset. The integrative analysis was performed between miRNAs differentially expressed in GSE44179 and regulatory TargetScandetected miRNAs of mRNAs differentially expressed in GSE4745. Pla2g2a and Hk2 mRNAs were up-anddown regulated, respectively, in GSE4745 on days 3 and 42 after diabetes-induction. The Pla2g2a regulatory miRNAs, rno-miR-877, rno-miR-320 and rno-miR-214, were down-regulated, and Hk2 regulatory miRNAs, rno-miR-17, rno-miR-187, rno-miR-34a, rno-miR-322, rno-miR-188, rno-miR-532 and rno-miR-21, were upregulated in GSE44179 dataset. These results are suggestive that Pla2g2a and Hk2 mRNAs and their regulatory miRNAs play a role in DCM pathogenesis and they may be potential circulating biomarkers to detect early cardiovascular complications in diabetic patients.
INTRODUCTION
Diabetes is a group of heterogeneous metabolic disorders which has in common the hyperglycemia triggered by a defect in insulin action and/or secretion (1) . Diabetes is one of the most common metabolic disorders in the world and its prevalence in adults has been increasing in the last decades (2, 3) . In 2013, 382 million people had diabetes; this number is expected to rise to 592 million by 2035 (2) .
Studies using diabetes-induced animal models have also shown structural, functional and molecular alterations in LV related to the hyperglycemic status (12) (13) (14) . Insulin-like growth factor 1 receptor activation was shown to prevent diabetes-induced cardiac fibrosis and diastolic dysfunction (12) . Inflammatory condition is triggered by hyperglycemia in diabetic patients, and has been associated with an over expression of many inflammatory mediators in LV, such as tumor necrosis factor-alfa, interleukin 1beta (13) and transforming growth factor beta (TGF β) (14) . Also, in the hyperglycemic condition, the levels of the collagen degrading matrix metalloproteinase 2 (MMP-2) decreases, suggesting that normalizing the MMP-2 activity is possible to prevent cardiac fibrosis in STZinduced cardiomyopathy (14) .
Molecular mechanisms involved in DCM physiopathology are not completely elucidated. It has been reported that hyperglycemia-induced BNIP3 expression, a protein involved in mitochondrial function and apoptosis in the heart, may compromise cardiac cell survival and function (15) . On the other hand, up-regulation of rno-miR-1 and rno-miR-206 related to down-regulation of Hsp60 mRNA target, in myocardium rats, neonatal ventricular cardiomyocytes, and H9C2 cells exposed to high levels of glucose, were associated with cardiomyocyte apoptosis (16) . These studies provided relevant information to understand some of the genes involved in DCM mechanisms. However, a systematic biology approach has not been used to investigate a broader range of genes that could be involved in DCM physiopathology.
The systematic biology approach using an in silico analysis (17) may be an alternative approach in order to expand the comprehension of miRNAregulated mRNA differential expression and its role in the development of DCM. Integrative analysis evaluating miRNA-mRNA target interactions has been performed to elucidate the pathogenesis of some diseases. Through in silico analysis using datasets of platelet miRNA and blood mRNA expression profiles of CAD in patients and healthy controls available at Gene Expression Omnibus (GEO) platform, investigators analyzed the prediction of miRNAs to target mRNAs dysregulated in CAD such as, TFEC-has-miR-545 and hsa-miR-585-SPOCK1 (18) .
Thus, the interactions between miRNAs and mRNAs differentially expressed in LV of diabetesinduced rats were evaluated using bioinformatic tools, aiming to identify mRNAs and their regulatory miRNAs, which play a role in DCM pathogenesis.
METHODS

Study design and experimental models
mRNA and miRNA expression profiles (GSE4745 and GSE44179, respectively) were downloaded from GEO datasets (19) . GSE4745 is a microarray dataset of global mRNA expression in ventricles of Wistar rats with diabetes induced by streptozotocin (STZ) at three time points: 3 days (n=4), 28 days (n=4) and 42 days after STZ injection (n=4). Control rats were injected with citrate buffer at the same time points: 3 (n=4), 28 (n=4) and 42 (n=4). Diabetic rats showed increased blood glucose 4.3., 5.6. and 5.0. fold, and ventricle weight/body weight ratio of 0.9.1, 0.9.9 and 1.3.5 fold, respectively, at 3, 28 and 42 days after STZ-induction compared to controls (p-value <0.0.5). mRNA expression was analyzed by the microarray system using the platform: GPL85 (RGU34A) Affymetrix Rat Genome U34 Array. The investigators that performed GSE4745 data published a study which investigated the conversion of acyl-carnitine in a long-chain free fatty acid and the exported system in mitochondria of STZ-diabetic rat hearts (20) .
GSE44179 is a microarray dataset of global miRNA expression in LV of diabetic (n=4) and nondiabetic (n=2) Wistar rats. Diabetes was induced by STZ followed by high fat diet for 12 weeks. Control rats (n=2) were fed with regular chow and citrate buffer injection. The diabetes rats' blood levels of glucose (556 ± 108 mg/dL), total cholesterol (140 ± 55 mg/ dL) and triglycerides (79 ± 21 mg/dL) were higher in diabetic than in control rats at the time of euthanasia (p-value <0.0.5). Intraperitoneal glucose tolerance test and Intraperitoneal insulin resistance test confirmed the glucose intolerance and insulin resistance in © 1996-2017 diabetic rats. DCM in rats was demonstrated by 1.6.-fold increase in a heart-to-body weight ratio and the presence of non-ischemic lesions, interstitial and perivascular fibrosis as well as myocytes atrophy and hypertrophy. miRNA expression was analyzed by the microarray system using the platform: GPL14613 (miRNA-2_0) Affymetrix Multispecies miRNA-2_0 array. The investigators that performed GSE44179 data evaluated the role of Cdc42 and Pak1 genes and rnomiR-30c in rats with DCM (21) . The in silico analysis strategy used in this study is described in Figure1. 
Microarrays data processing
Rat LV mRNA expression from GSE4745 dataset was compared between diabetic and control rats of each experimental period (3, 28 and 42 days after STZ diabetes induction), using Gene Expression Omnibus 2R (GEO2R). GEO2R (22) is a tool which allows comparison of data from two or more groups of samples in order to identify genes that are differently expressed in experimental conditions. Three top lists of mRNAs differentially and significantly expressed (|FC| > 2; p-value <0.0.5) at each study period were selected. Additionally, when the mRNAs that were repeated in the top list were considered, only the mRNA with the best p-value and when p-value or FC were out of the cutoff, the mRNAs were not evaluated.
The list of top LV miRNAs differentially expressed (|FC| > 2; p-value <0.0.5) of diabetic and control rats from GSE44179 dataset were also selected using GEO2R. The repeated miRNAs of the top list were considered the only one which had the best p-value and when P-value or FC was out of the cutoff, the miRNAs were not evaluated.
DCM-related gene study
The mRNAs differentially expressed were filtered by |FC| > 2 and p-value <0.0.5 after the analysis by GEO2R and were uploaded into the Ingenuity Pathway Analyses 6 (IPA) software, to identify interactions between genes and to create networks including upstream regulators, signaling pathways, physiological systems and pathophysiological Figure 1 . In silico analysis strategy of mRNA-miRNA differential expression data associated with diabetes-induced cardiotoxicity. Left ventricle of STZ-induced diabetic rats was used for microarray analysis. GEO2R: Gene Expression Omnibus 2R software; GEO, Gene Expression Omnibus; IPA, Ingenuity Pathway Analyses 6; MICRORNA, microRNA database. © 1996-2017
processes. The IPA-cardiac functional tool was used to select the genes involved in cardiotoxicity (hypertrophy, fibrosis and necrosis/cell death) and to generate a summary list of DCM-related mRNAs differential expression for each period of exposure to STZ, according to GSE4745 dataset.
Regulatory miRNAs of DCM-related mRNAs
TargetScan 7.1. web dataset (23) was used to search the regulatory miRNAs of the DCM-related mRNAs differentially expressed LV of rats at the three periods of the STZ treatment. The analysis uses algorithms for target site predictions based on miRNAmRNA interactions and provides a context++ model of miRNA target efficacy which is the more predictive than any published model and at least as predictive as the most informative in vivo crosslink approaches. The miRNA-mRNA interactions according to IPA software and TargetScan 7.1. web dataset were constructed in the IPA tool.
Integrative mRNA-miRNA analysis
The integrative analysis was performed using the miRNAs differentially expressed in GSE44179 dataset and the miRNAs selected by the TargetScan 7.1. web dataset predictive tools, as having a regulatory role on GSE4745 differentially expressed mRNAs. The Venn diagram was used to evaluate the number of miRNAs commonly found in both sets of miRNAs.
Statistical analysis
The Limma (linear models for microarray data) was used to summarize the results of the linear model, perform hypothesis tests and to adjust the p-values for multiple testing (24). The Fold-Change (FC) is a measuring of the changes in the expression level of a gene, and it was considered significant when |FC| > 2.0. between two experimental conditions (control and diabetic samples in both datasets). The Benjamini & Hochberg false discovery rate method was selected because it is the most commonly used method for adjustment of p-values for analysis of microarray data and provides a good balance between discovery of statistically significant genes and limitation of false positives; p-value <0.0.5 was considered significant. The context++ score generated by TargetScan 7.1. web dataset is a method used to predict miRNA target efficacy (23).
RESULTS
mRNA and miRNA differentially expressed in rat LV
The analysis of mRNAs differentially expressed in LV of STZ-induced diabetic rats resulted in 3 lists of 85, 113 and 154 mRNAs that were differentially and significantly expressed considering |FC| > 2; p-value <0.0.5, significant values, respectively, at 3, 28 and 42 days after STZ induction, compared to control rats (Table 3 ).
The data from GSE44179 showed that 29 miRNAs were differentially and significantly expressed (|FC| > 2; p-value <0.0.5) in LV of rats with diabetes induced by high fat diet and STZ in comparison with non-diabetic rats. Eleven miRNAs were downregulated: rno-mir-122, rno-mir-184, rno-mir-151, rnomiR-194, rno-mir-22, rno-mir-214, rno-miR-30-c2*, rno-mir-320, rno-mir-204, rno-mir-342 and rnomir-877; and eighteen were up-regulated: rno-mir-34a, The relationship between cardiac dysfunction and DCM-related mRNAs carried out by IPA software using mRNAs downloaded from GSE4745 dataset. 1 mRNAs differentially expressed in three time points (Hk2 and Pla2g2a). DCM: diabetic cardiomiopathy © 1996-2017 rno-miR-7a, rno-mir-532, rno-mir-21, rno-mir-200c, rno-miR-17-3p, rno-miR-7a*, rno-mir-186, rno-mir-203, rno-mir-322, rno-mir-187, rno-mir-92b, rno-mir-148b, rno-mir-466c, rno-mir-20b, rno-miR-9*, rno-mir-188 and rno-mir-199a compared to control rats (Table 4 ).
DCM-related differentially expressed mRNAs
The DCM-related gene analysis by the IPA cardiac function tool showed that seven differentially expressed mRNAs (GSE4745 dataset) were associated with cardiotoxicity (Table 1 and Table 5 ). Hk2 gene was associated with cardiac necrosis and cell death, at 3, 28 and 42 days after STZ-induced diabetes. Nppa and Txnip at 28 and 42 days, and Fstl1 and Hspb1 at 42 days, were also associated with cardiac necrosis and cell death by different mechanisms. The Pla2g2a gene was related to cardiac fibrosis at all periods studied, whereas Agtr1 and Nppa were associated with cardiac hypertrophy, after 28 and 42 days of the STZ treatment.
Regarding the fold regulation of the DCMrelated mRNAs at day 3 after STZ-induction, the Pla2g2a was up-regulated (LogFC 1.0.5) and Hk2 down-regulated (LogFC -1.8.82); at day 28, Hk2 and Agtr1a were up-regulated (LogFC 2. 
Regulatory miRNAs of DCM-related mRNAs
The TargetScan 7.1. web dataset predicted regulatory miRNAs of the DCM-related mRNAs from the previous analysis of the GSE4745 dataset. miRNAs target Pla2g2a (23 miRNAs), Hk2 (175 miRNAs), Agtr1 (78 miRNAs), Nppa (22 miRNAs), Fstl1 (196 miRNAs), Hspb1 (11 miRNAs) and Txnip (134 miRNAs) ( Table 6 ).
mRNA-miRNAs Integrative Analysis
The Venn diagram was performed to evaluate the relationship of miRNAs found differentially expressed in the GSE44179 and the regulatory miRNAs of DCM-related mRNAs differentially expressed in the periods evaluated in GSE4745 dataset (Figure 2) . Interestingly, ten miRNAs (rno-mir-214, rno-mir-320, rno-mir-877, rno-mir-34a, rno-mir-532, rno-mir-21, rnomiR-17-3p, rno-mir-322, rno-mir-187 and rno-mir-188) were differently expressed in the GSE44179 data (Table 4 ) and were associated with the DCM-related mRNAs in all periods evaluated, as shown in Table 2 .
The Hk2 was down-regulated at 3 and 42 days after the STZ-induction (logFC -1.8.82 and -4.1.59, respectively). It mRNA could be regulated by rno-mir34a (LogFC 2.6.06), rno-mir-532 (LogFC 2. (Table 2 and Table 4 ).
The mRNA-mRNA and miRNA-mRNA interactions according to the IPA software and TargetScan 7.1. web dataset are shown at Figure 3 . Possible pathways associated with DCM development: gene-gene: Agtr1-Nppa, Agtr1-Txnip; miRNA-target mRNAs: Agtr1 (rno-miR-7a, rno-miR-194, rno-mir-188, rno-mir-204 and rno-mir-466c); Fstl1 (rno-mir-203, rno-mir-322, rno-mir-22, rno-mir-200c, rno-mir-342, rno-mir-877, rno-mir-204, rno-mir-92b, rno-mir-214, rno-miR-30-c2*, rno-miR-7a, rno-miR-17-3p, rno-mir20b, rno-mir-186 and rno-mir-320); Txnip (rno-mir-20b, rno-mir-204, rno-mir-342, rno-mir-322, rno-mir-214, rno-miR-7a, rno-mir-22, rno-mir-320, rno-mir-186, rnomir-148b, rno-mir-532 and rno-miR-17-3p); Pla2g2a (rno-mir-214, rno-mir-320 and rno-mir-877); Hk2 (rnomir-34a, rno-mir-532, rno-mir-21, rno-miR-17-3p, rno-mir-322, rno-mir-187, rno-mir-188, rno-mir-214, rno-mir-320, rno-mir-184 and rno-mir-342); Hspb1 (rnomir-199a); Nppa (rno-miR-30-c2* and rno-miR-194) and miRNA-miRNA: rno-mir-214-rno-mir-148.
DISCUSSION
In this study, Pla2g2a was up-regulated in LV of diabetic rats in an acute and chronic condition, which is suggestive that it may be involved in LV dysfunction induced by hyperglycemia. PLA2G2A is a phospholipase A2 group II A which catalyses the hydrolyzes of the acyl group at the sn-2 position of glycerophospholipids forming non-esterified fatty acids and lysophospholipids and plays a critical role in inflammation (25) . Transgenic mice expressing an extracellular group IIa phospholipase A2 (sPLA2) have a higher number of atherosclerotic lesions when maintained on a high-fat, high-cholesterol and a low-fat chow diet in comparison with non-transgenic littermates. Immunohistochemical staining indicated that sPLA2 was present in the atherosclerotic lesions of the transgenic mice, which suggests that sPLA2 may promote atherogenesis, in part, through its effects on lipoprotein levels, increasing LDL cholesterol and decreasing HDL cholesterol. These data are suggestive that increased sPLA2 is involved in lipid-driven atherosclerosis, which is an important risk factor for CAD and possible other chronic inflammatory diseases (26) . © 1996-2017
Another study involving the measurement of serum levels of sPLA2 activity and secretory phospolipase A 2 type IIA (sPLA2-IIA) evaluated the increase of circulating sPLA2-activity and sPLA2-IIA in patients with stable CAD suggesting their relation with functional characteristics of coronary stenosis in these patients. Measuring these molecules could be a possibility to predict the severity of CAD (27) . The prognostic value of the sPLA2 activity in patients with an acute coronary syndrome (ACS) was determined through a measurement of sPLA2 antigen levels and its activity in plasma samples. The results showed that the high plasma sPLA2 activity is a major independent predictor of death and new or recurrent myocardial infarction (MI) in patients with ACS (28) . Based on these previous studies and the hyperglycemia-induced Pla2g2a up-regulation in rats LV, it is likely that this gene plays an important role in the pathopysiology of DCM.
Pla2g2a regulatory miRNAs, rno-miR-877, rno-miR-320 and rno-miR-214, were down-regulated in LV of rats exposed to a high glucose concentration, suggesting their involvement in the development of DCM. Despite the down regulation of rno-miR-877 in ventricles of diabetic rats observed in GSE44179 dataset, there are only a few studies about these miRNA, especially in DCM. Researchers evaluated the expression profiles of miRNAs in single-cell suspensions in the lung prepared from C57BL/6 mice, before and after myofibroblast differentiation of lung resident mesenchimal stem cells and observed that the miR-877-3p is highly up-regulated in the myofibroblast differentiation and in the fibrotic lung. In addition, they found that miR-877-3p sequestration inhibited the myofibroblast differentiation, suggesting a potential application of miR-877-3p as a fibrosis suppressor in pulmonary fibrosis therapy and as a fibrosis marker for predicting prognosis, which indentified that miR-877-3p, is a miRNA that acts as a supressor in pulmonary fibrosis (29) .
Regarding rno-miR-320, an in vivo study using an animal model evaluated the role of rnomiR-320 in ischemia/reperfusion (I/R). They observed that miR-320 expression worsens myocardial I/R injury, while its inhibition protects against myocardial apoptosis, mainly via the Insulin Growth Factor 1 (IGF-1) pathway, affecting the levels of antiapoptotic signaling pathways. This suggests miR-320 may represent a valuable tool and potential therapeutic target for protection against I/R induced cardiac injury (30) . Although, in our integrative analysis, the rnomiR-320 was down-regulated in DCM, the association of this miRNA with apoptosis may represent an important finding.
Rno-miR-214 is a bi-functional cardio-miR, which is involved in cardiac physiology (31) . In the dataset analyzed, rno-miR-214 was down-regulated in LV of diabetic rats, which is suggestive of its role in DCM through the regulation of the Pla2g2a gene expression. Supporting our hypothesis, the miR-214 was also observed down-regulated in blood samples of patients with acute MI, and angina pectoris, suggesting that the low expression of hsa-miR-214 is associated with severity of coronary stenosis and it could be a promising biomarker for CAD (32) . Moreover, a model of mmu-miR-214 knockout mice showed a loss of cardiac contractility, increased apoptosis, and excessive fibrosis in response to ischemia/reperfusion injury (33) , supporting the role of this miR in DCM complication.
The analysis also showed that Hk2 mRNA was down-regulated and related to the high expression of its regulatory miRNAs (rno-miR-17, rno-miR-187, rno-miR-34a, rno-miR-322, rno-miR-188, rno-miR-532 and rno-miR-21) in LV of rats exposed to a high glucose concentration, suggesting their important role in the pathophysiology of DCM.
Hk2 is an isozyme which occurs in mammalian tissue and catalyzes glucose phosphorylation. It has an affinity for glucose and product inhibition for glucose-6-phosphate (34, 35) . Additionally, a study observed the role of mitochondria-bound hexokinase 2 (mTHK2) in cardio protection using hearts of ischemic preconditioning rats whose results suggest that mtHK2 stimulates reactive oxygen species (ROS) production and mitochondrial permeability transition pore opening on reperfusion, leading to MI, during ischemia (36) . Moreover, a study using an animal model of heterozygous HK2-deficient mice displayed increased hypertrophy and heart failure in response to transverse aortic constriction, as well as, there being an increased ROS production and de novo hypertrophy, suggesting that the use of some methods to increase the HK2 levels could control the cardiac hypertrophy (37) .
As for the regulatory miRNAs of Hk2, an in vitro study was performed to detect if whether the miR-17-5p is differentially expressed in ischemia and reperfusion mice model and neonatal rat ventricular cardiomyocytes (NRCVs) under oxidative stress. The investigators suggested that overexpression of miR-17-5p increases the damage in cardiomyocyte through reduction of cell viability and increasing apoptosis (38) , this result reinforces the correlation of rno-miR-17 with apoptosis in cardiomyocites and it relation with Hk2 mRNA. The hsa-miR-187 was found differentially expressed in studies that analyzed doxorubicin (DOX)-cardiotoxicity induced in cell culture. They showed an early deregulation in miR-187 expression by real-time PCR analyses in human-induced pluripotent stem cellderived cardiomyocytes exposed to DOX which was very important and links this miRNA to its use as an early sensitive cardiotoxicity biomarker (39, 40) . © 1996-2017
Regarding rno-miR-34, its miRNA has been associated with cardiac problems (41, 42) . In a previous in vivo study that induced cardiac injury in neonatal and adult hearts, it was observed that miR-34 could act in cardiac repair and regeneration through its regulation of mRNA targets such as B-cell lymphoma 2 (Bcl2), Cyclin D1 and Sirtuin 1 (Sirt1), and are related with the cell apoptosis precess (41) . In addition, in an in vitro study using an in vitro anoxia and reoxygenation injury (ARI) model based on rat heart-derived H9c2 cells, it has suggested an important relation of it miRNA in cardiac function. The cells were treated with Resveratrol, a natural polyphenolic compound, which suppresses the effects of rno-miR-34a upregulation in anoxia and reoxygenation injury, suggesting a cardiac protective effect on cardiomyocytes in ARI (42) .
Study using RNA sequencing also corroborates with our in silico results, showing an upregulation of rno-miR-322-3p in in vitro study using neonatal heart cells in hypertrophy model (43) . In cardiac injury, the expression of rno-miR-322 in vivo was measured in the rat carotid artery after injury and in vitro in rat vascular smooth muscle cells (VSMC) proliferantion and in both analyses, the rno-miR-322 were up-regulated after vascular injury, suggesting that the miRNA could be a useful therapeutic target to inhibit VSMC dedifferentiation during a vascular occlusive disease (44) .
Regarding rno-miR-21-5p, an unbiased quantitative miRNA microarray analysis the right and left ventricles of normal and pulmonary arterial hypertension rats observed an upregulation of rno-miR-21-5p in a pulmonary arterial hypertension condition (45) . In mice, the mmu-miR-21-5p has been associated with increased cardiac fibrosis, and its upregulation was observed in the heart of a myocardial infarction animal model, suggesting that this miRNA may act regulationg the suppression in TGF-β via, and consequently increasing the production of collagen (46) .
Rno-miR-188-3p
participates in the suppression of autophagy and myocardial infarction by targeting ATG7 in an in vitro and in vivo model of myocardial infarction in rats (47) . Another study of miRNA microarray assay concludes that rno-miR-188 is the most downregulated miRNA in homocysteine cardiac remodeling in vitro model which suggests that it miRNA acts in cardiac remodeling in cardiovascular diseases (48) .
The association between miR-532 and heart disease was observed in a study evaluating miRNAs levels in endothelial-like cells of human volunteers. The endothelial-like cells were cultured under hypoxia and normoxia conditions and the hsa-miR-532 was upregulated under hypoxia conditions when compared to normoxia conditions (49) . Therefore, up regulation of rno-miR-17, rnomiR-187, rno-miR-34a, rno-miR-322, rno-miR-188, rno-miR-532 and rno-miR-21 and down regulation of the Hk2 mRNA target could lead to a loss of cardio protection and consequently to the development of cardiac complications, including those associated with a hyperglycemic condition.
Despite the interesting findings of this in silico study, there are some limitations including the need to validate data from hyperglycemia-induced mRNAs and regulatory miRNAs interactions and roles in experimental models. Besides our focusing on hyperglycemia effects, two different animal models of diabetes (type 1 and 2) were used to investigate mRNA and miRNAs differentially expressed in LV rats. However, it has been shown that both models develop hyperglycemia leading to structural and functional alterations in LV in both types of diabetes (50).
In conclusion, the differential expression of Pla2g2a and Hk2 mRNA and their interactions with regulatory miRNAs rno-miR-877, rno-miR-320 and rno-miR-214 (Pla2g2a) and rno-miR-17, rno-miR-187, rno-miR-34a, rno-miR-322, rno-miR-188, rno-miR-532 and rno-miR-21 (Hk2) could be associated with DCM in rats. These miRNAs and mRNAs targets may be useful biomarkers to detect early cardiovascular complications of diabetic patients. 
